Diverse patient trajectories during cytotoxic chemotherapy: Capturing longitudinal patient‐reported outcomes
Abstract Background High‐value cancer care balances effective treatment with preservation of quality of life. Chemotherapy is known to affect patients’ physical and psychological well‐being negatively. Patient‐reported outcomes (PROs) provide a means to monitor declines in a patients’ well‐being dur...
Main Authors: | Amee D. Azad, Melih Yilmaz, Selen Bozkurt, James D. Brooks, Douglas W. Blayney, Tina Hernandez‐Boussard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4124 |
Similar Items
-
Two-item PROMIS® global physical and mental health scales
by: Ron D. Hays, et al.
Published: (2017-09-01) -
Dutch reference values for the Patient-Reported Outcomes Measurement Information System Scale v1.2 - Global Health (PROMIS-GH)
by: Ellen B. M. Elsman, et al.
Published: (2021-05-01) -
Mapping of the PROMIS global health measure to the PROPr in the United States
by: Ron D. Hays, et al.
Published: (2024-01-01) -
The promise of computer adaptive testing in collection of orthopaedic outcomes: an evaluation of PROMIS utilization
by: Liam H. Wong, et al.
Published: (2022-01-01) -
Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
by: Peipert JD, et al.
Published: (2020-06-01)